Opendata, web and dolomites

PREKIND

PreEclampsia diagnosis by Early Kidney Injury Detection

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PREKIND project word cloud

Explore the words cloud of the PREKIND project. It provides you a very rough idea of what is the project "PREKIND" about.

cardiovascular    exceptional    ongoing    pregnant    vesna    prognostic    diagnostic    cytometry    form    clinic    renal    informbio    pe    disease    provision    risk    clinical    predict    contribution    ruo    symptoms    org    000    7billion    develops    feasibility    damage    500    preeclampsia    business    demonstrated    mayo    diagnose    http    licensed    introduction    surviving    31billion    75    life    specificity    elisa    months    leader    spend    flow    innovative    women    lives    care    podocyte    ambition    plan    garovic    estimates    sensitivity    too    year1    direct    sub    survive    conduct    dr    world    antenatal    biomarkers    rest    biomarker    syndrome    solutions    podocin    infant    tests    diagnosis    urine    deaths    pioneering    emerge3    dealing    accounts    alone    millions    budgets    complications    health    pregnancy    indicate    claims    foundation    annual    worldwide    ib    variety    assays    annually    usa    babies    preelampsia    innovation    mothers   

Project "PREKIND" data sheet

The following table provides information about the project.

Coordinator
INFORM BIOSCIENCE LIMITED 

Organization address
address: HOFFMAN PARK LITTLE ISLAND COUNTY CORK
city: CORK
postcode: n.a.
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Project website http://www.informbio.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-05-01   to  2015-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INFORM BIOSCIENCE LIMITED IE (CORK) coordinator 50˙000.00

Map

 Project objective

Health Challenge: PreEclampsia (PE) claims the lives of 75,000 women annually and the 6,000,000 surviving mothers will have an increased risk of cardiovascular disease for the rest of their life. PE accounts for over 500,000 infant deaths worldwide every year1; and for the millions of babies that survive, they too will go on to have increased risk of a variety of health issues. PE is a syndrome that develops during pregnancy but presents no clinical symptoms during most of the pregnancy and is therefore currently complex to diagnose. Business Challenge: With an annual spend of over 31Billion in direct costs in the developed world alone, the provision of antenatal care to pregnant women has a significant impact on health care budgets; dealing with the immediate consequences of PE form an important contribution to this cost. The Preelampsia foundation (http://www.preeclampsia.org/) estimates the annual cost of PE is more than $7billion in the US. InformBio Business Innovation: InformBio (IB) has licensed pioneering research by Dr.Vesna Garovic of the Mayo Clinic, USA. The technology has identified podocyte specific biomarkers in urine that indicate ongoing renal damage and which allow for a sub-clinical diagnosis for PE. The key biomarker, podocin, has demonstrated exceptional sensitivity and specificity and can diagnose the disease up to 3 months before clinical symptoms emerge3. InformBio are currently working to develop flow cytometry and research use only (RUO) ELISA assays for the biomarker. InformBio’s ambition is to be the world leader in early pregnancy prognostic tests, offering the most innovative, cost effective solutions to predict pregnancy complications.

Phase 1 proposal: To conduct a feasibility study to support the development of a detailed business plan for the introduction of a PE diagnostic test.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PREKIND" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PREKIND" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More  

INTE-AFRICA (2019)

Integrating and decentralising diabetes and hypertension services in Africa

Read More  

FAIR (2020)

FLAGELLIN AEROSOL THERAPY AS AN IMMUNOMODULATORY ADJUNCT TO THE ANTIBIOTIC TREATMENT OF DRUG-RESISTANT BACTERIAL PNEUMONIA

Read More